Sign in

RASopathies Network

@rasnet.bsky.social
464 followers 823 following 351 posts

Nonprofit research advocacy org for conditions caused by dysfunctional RAS/MAPK signaling. #rasopathies #raredisease by Stronach in Pittsburgh

PostsRepliesMedia
Reposted by RASopathies Network
The Conversation U.S. @us.theconversation.com · 12h
Redevelopment without gentrification? A decade of research on Pittsburgh's Hazelwood neighborhood finds that the major riverfront investment was done without pushing out longtime residents.
theconversation.com
Can development happen without displacement? Pittsburgh’s Hazelwood neighborhood is a test case
A decade of research on Pittsburgh’s Hazelwood neighborhood finds that major riverfront investment did not push out longtime residents.
01810
Reposted by RASopathies Network
Princess Vimentin PhD | Cancer Biologist @princess-vimentin.bsky.social · 02/10/2026
This is huge! Another cancer responds well to immunotherapy. A child had metastatic liver cancer. The patient had chemotherapy & a liver resection. No avail. Then: Two infusions, eight weeks apart. Doctors saw complete regression. No systemic toxicity. 🧪 www.bcm.edu/news/care-st...
bcm.edu
CARE study reports complete regression of liver cancer in a child treated with novel immunotherapy
A new report in the New England Journal of Medicine by researchers at Baylor College of Medicine, Texas Children’s Hospital and Seattle Children’s...
492014695
Reposted by RASopathies Network
RASopathies Network @rasnet.bsky.social · 02/10/2026
Yes, Thanks for asking. There are numerous clinical case studies. Here are a few related to Noonan syndrome. www.mdpi.com/1422-0067/26...
Picture of scientific publication, titled "Targeted therapy for complex lymphatic anomalies in patients with noonan syndrome and related disorders"text from the paper with a highlighted section. "Lymphatic anomalies are a major feature in Noonan syndrome (NS), with a lifetime prevalence of approximately 37%"
101
Reposted by RASopathies Network
The Ehlers-Danlos Society @ehlers-danlos.com · 02/10/2026
October is Dysautonomia Awareness Month. ⁠ ⁠ Dysautonomia, also called autonomic dysfunction, is a group of disorders that affect the autonomic nervous system.⁠ ⁠
Graphic titled “Symptoms of Dysautonomia” showing seven human silhouettes illustrating common symptoms: tachycardia (fast heart rate), hypotension (low blood pressure), dizziness or lightheadedness, gastrointestinal dysmotility (problems moving food through the digestive system), temperature and sweating dysregulation, sleep problems, and bladder issues.
22714
RASopathies Network @rasnet.bsky.social · 02/10/2026
Oooh, excited to learn more on @scifri.bsky.social 1 in 5 people w a RASopathy condition have lymphatic problems and it can be devastating in newborns See: Central Conducting Lymphatic Anomalies
100
Reposted by RASopathies Network
American Association for Cancer Research (AACR) @theaacr.bsky.social · 28/09/2026
AACR and Kids Beating Cancer announced a new grant at the AACR Special Conference on Pediatric Cancer that will fund researchers who are studying pediatric leukemia. Read more about this new collaboration and the grant on the #AACRBlog: buff.ly/Kp7EVE4 #AACRpediatric26
buff.ly
AACR and Kids Beating Cancer Launch New Grant to Advance Pediatric Leukemia Research
AACR and Kids Beating Cancer launched a new grant to support research aimed at improving outcomes for children with high-risk leukemia.
012
RASopathies Network @rasnet.bsky.social · 27/09/2026
Happy to see this.
020
Reposted by RASopathies Network
Nick (derogatory) ✨ @slothropsmap.bsky.social · 26/09/2026
Ghost lobster, ghost lobster! Read all about it!
people.com
Meet Casper, the 1-in-100-Million White ‘Ghost’ Lobster Helping Scientists Crack a Genetic Mystery
The white lobster, aptly named Casper, has arrived at the University of New England, where researchers are working to uncover why some lobsters develop dramatically unusual shell colors
816628
Reposted by RASopathies Network
Sarah McAnulty, Ph.D. @sarahmackattack.bsky.social · 26/09/2026
Anybody who would decide to close this museum does not have Philadelphia’s best interests at heart.
11751194
Reposted by RASopathies Network
AACR Journals @aacrjournals.bsky.social · 25/09/2026
Read: "RAS Pathway Activation and Microenvironmental Adaptation as Hallmarks of Myeloid Sarcoma" from this month's issue of Blood Cancer Discovery. buff.ly/O9S6B09
001
Reposted by RASopathies Network
CT Rare Advocate @rarectadvocate.com · 23/09/2026
Hypoplastic Left Heart Syndrome (HLHS): a rare congenital heart defect where the left side of the heart is underdeveloped. Often found on prenatal ultrasound; treated with staged surgeries. Learn more: littlehearts.org You may be rare, but you're not alone! #rareDisease #rareDiseaseAwareness
Info card for Hypoplastic Left Heart Syndrome (HLHS), a rare congenital heart defect in which the left side of the heart is severely underdeveloped. The card notes that HLHS is often detected on prenatal ultrasound and is treated with a series of three surgeries. Key symptoms include bluish skin color, fast breathing, and poor feeding. Footer reads: "You may be rare, but you're not alone! rarectadvocate.com"
031
Reposted by RASopathies Network
RASopathies Network @rasnet.bsky.social · 15/09/2026
🧪💊Excited to share another #RASDialogueBlog post from NCI's Frederick National Labs. Could a new molecular glue targeting #RAF and #RAS pathway be used to normalize signaling for #Noonansyndrome patients? Work from the lab of Michelle Arkin! #oncosky #medsky frederick.cancer.gov/news/restori...
frederick.cancer.gov
Restoring the brake: Using molecular glues to fix a broken CRAF off-switch in Noonan Syndrome | Frederick National Laboratory
The RAS Dialogue Blog posts are written by RAS experts sharing the latest research, updates, and scientific RAS news. The content is curated by the RAS Initiative.
032
Reposted by RASopathies Network
American Association for Cancer Research (AACR) @theaacr.bsky.social · 15/09/2026
Submit an abstract by November 2 for the AACR Conference on Targeting RAS: Mechanisms, Novel Therapeutics, and Clinical Impact (January 28-31; San Diego), chaired by Ryan B. Corcoran, Julian Downward, Ignacio Garrido-Laguna, and Sandra Misale. buff.ly/i0N1m1e #AACRras27 @juliandownward.bsky.social
011
RASopathies Network @rasnet.bsky.social · 15/09/2026
🧪💊Excited to share another #RASDialogueBlog post from NCI's Frederick National Labs. Could a new molecular glue targeting #RAF and #RAS pathway be used to normalize signaling for #Noonansyndrome patients? Work from the lab of Michelle Arkin! #oncosky #medsky frederick.cancer.gov/news/restori...
frederick.cancer.gov
Restoring the brake: Using molecular glues to fix a broken CRAF off-switch in Noonan Syndrome | Frederick National Laboratory
The RAS Dialogue Blog posts are written by RAS experts sharing the latest research, updates, and scientific RAS news. The content is curated by the RAS Initiative.
032
Reposted by RASopathies Network
Matt Henderson @matthen.com · 13/09/2026
Approximating the Lorenz attractor with a chaotic leaky water wheel. The orange dot is the centre of mass of the water. It traces (a projection of) the familiar attractor as the wheel spins seemingly randomly left and right.
14738151
RASopathies Network @rasnet.bsky.social · 11/09/2026
🧪🧠🫀🩺 NEW: Evaluation of Molecular Genetics and Clinical Manifestations in Patients With LZTR1‐Associated Noonan Syndrome: A Retrospective Chart Review and Review of Literature onlinelibrary.wiley.com/doi/10.1002/... #pedsky #medsky #cardiosky
onlinelibrary.wiley.com
The Evaluation of Molecular Genetics and Clinical Manifestations in Patients With <fc><fi>LZTR1</fi></fc>‐Associated Noonan Syndrome: A Retrospective Chart Review and Review of Literature
Pathogenic variants in LZTR1 are an established cause of Noonan syndrome (NS) and uniquely exhibit both autosomal dominant (AD) and autosomal recessive (AR) inheritance. However, the phenotypic spect....
052
Reposted by RASopathies Network
UCSF Helen Diller Family Comprehensive Cancer Center @ucsfcancer.bsky.social · 11/09/2026
In the latest @cancerletter.com podcast, Dr. Frank McCormick @ucsanfrancisco.bsky.social discusses the wider implications of the recent FDA approved the RAS inhibitor, daraxonrasib cancerletter.com/podcastc/202...
Frank McCormick, PhD, FRS of the UCSF Helen Diller Family Comprehensive Cancer Center
041
Reposted by RASopathies Network
Ricard Alert Zenón @ricardalert.bsky.social · 08/09/2026
New paper out @natcellbio.nature.com! In embryos, immune cell migration is guided by the surrounding tissue flow. In turn, tissue flow is captured by active wetting theory, generalized to include influx from the upper cell aggregate! Check the thread below! 👇 www.nature.com/articles/s41...
nature.com
Tissue flow acts as a guidance cue for immune cell polarization and directional migration - Nature Cell Biology
Le et al. show that in Xenopus embryos, local ectodermal tissue flows provide a directional cue that polarizes and guides embryonic myeloid cells migration via cell-on-cell interactions.
1328
Reposted by RASopathies Network
Science X / Phys.org @sciencex.bsky.social · 29/08/2026
Cancer drugs that block BRAF reduced sensitivity to touch, pressure and heat in preclinical models of chronic nerve pain. The findings suggest therapeutic potential, but dosing and side effects still need study. doi.org/hcg7s7
medicalxpress.com
Preclinical study points to cancer drugs as possible treatments for chronic nerve pain
Researchers at The University of Texas MD Anderson Cancer Center have found new evidence that BRAF, a protein commonly involved in cancer, plays a key role in developing, amplifying and maintaining chronic pain caused by nerve damage.
031
Reposted by RASopathies Network
Jeremy Berg @jeremymberg.bsky.social · 27/08/2026
Excited to see these traces of the history of important therapeutics. Today's is the first of 12. It is about ras and ras inhibitors. By coincidence/karma, the first ras inhibitor for pancreatic cancer was approved by the FDA yesterday. Reactions and comments welcome! @standupforscience.net
24616
Reposted by RASopathies Network
Simon Fisher @profsimonfisher.bsky.social · 27/08/2026
“This work establishes a scalable framework for systematic interrogation of the autism proteome, enables prioritization of druggable protein interfaces, & provides a rational foundation for precision therapeutic strategies aimed at restoring neurodevelopmental trajectories.” New in @science.org 👇🧪
science.org
Autism mutations rewire protein interaction networks to drive neurodevelopmental pathology
Systematic mapping of protein-protein interaction (PPI) networks and determining how causal mutations rewire them in autism spectrum disorder (ASD) provide a powerful framework for uncovering disease ...
1173
Reposted by RASopathies Network
Carl Zimmer @carlzimmer.com · 27/08/2026
Scientists are drawing the map of autism-linked proteins in search of treatments. Here’s a story on an ambitious new study. Gift link: nyti.ms/4wWPZpM
A map of autism-linked proteins (diamonds) and proteins they partner with (circles). Wang et al, Science 2026.
78223
Reposted by RASopathies Network
Stefan Marciniak @profmarciniak.bsky.social · 26/08/2026
“Recorded SARS-CoV-2 infection was associated with higher short-term risks of myocarditis, pericarditis, and all-cause mortality than recorded BNT162b2 vaccination in adolescents and young adults” Infection is worse than vaccination — who knew? www.sciencedirect.com/science/arti...
sciencedirect.com
Cardiac outcomes following SARS-CoV-2 infection versus BNT162b2 vaccination in adolescents and young adults: a cohort study of 4 million individuals
Concerns about myocarditis and mortality after COVID-19 vaccination in pediatrics persist despite limited direct comparisons with SARS-CoV-2 infection…
2115
Reposted by RASopathies Network
Josie Glausiusz @josiegz.bsky.social · 26/08/2026
In every science article I write, I'm always looking for the humanity inside the story. So it was a privilege to learn from researchers looking for new treatments for disabilities with which they themselves were diagnosed. My latest @natureportfolio.nature.com www.nature.com/articles/d41...
nature.com
Researcher, heal thyself: meet the scientists studying their own diseases
Studying a condition after being diagnosed with it can be rewarding but also presents some ethical and psychological challenges.
13014
Reposted by RASopathies Network
Memorial Sloan Kettering Cancer Center @mskcancercenter.bsky.social · 26/08/2026
The FDA has approved #daraxonrasib for certain patients with metastatic pancreatic cancer. MSK’s Dr. Eileen O'Reilly led the phase 3 trial showing it doubled median survival compared with chemotherapy. Learn more about the approval and what it could mean for patients: bit.ly/4zM7xYv
052
Reposted by RASopathies Network
RASopathies Network @rasnet.bsky.social · 25/08/2026
BRAF recruitment to spinal sensory synapses promotes neuropathic pain by potentiating transsynaptic NMDA receptor activity | Science Signaling www.science.org/doi/10.1126/...
science.org
BRAF recruitment to spinal sensory synapses promotes neuropathic pain by potentiating transsynaptic NMDA receptor activity
Blocking the kinase BRAF reduces nociceptive transmission in spinal cord after injury.
011
Reposted by RASopathies Network
CT Rare Advocate @rarectadvocate.com · 25/08/2026
Ménétrier Disease is a rare gastric disorder causing severe thickening of the stomach lining, driven by excess EGFR signaling, chronic protein loss, and elevated gastric cancer risk. Learn more: dub.sh/menetrier You may be rare, but you're not alone! #rareDisease #rareDiseaseAwareness
Info card for Ménétrier Disease, a rare gastric disorder in which overgrowth of the stomach lining causes chronic protein loss. The card notes it affects fewer than 1,000 people worldwide and lists epigastric pain and fatigue among key symptoms. Footer reads: "You may be rare, but you're not alone! rarectadvocate.com"
032
Reposted by RASopathies Network
The Company of Biologists @biologists.bsky.social · 26/08/2026
Deadline is 31 August to register for the Innovative Preclinical Models for Pediatric Cancer Research meeting, hosted by @dmmjournal.bsky.social. Hear talks from an outstanding line up of speakers and apply to present a poster. www.biologists.com/meetings/dmm...
1510
RASopathies Network @rasnet.bsky.social · 26/08/2026
from the Corning Museum, a feathery cube? -zoom in- #glass #imaging #microscopy
photo of a cube made from borosilicate coverslips at the Corning Museum in Corning, NY
000
RASopathies Network @rasnet.bsky.social · 25/08/2026
BRAF recruitment to spinal sensory synapses promotes neuropathic pain by potentiating transsynaptic NMDA receptor activity | Science Signaling www.science.org/doi/10.1126/...
science.org
BRAF recruitment to spinal sensory synapses promotes neuropathic pain by potentiating transsynaptic NMDA receptor activity
Blocking the kinase BRAF reduces nociceptive transmission in spinal cord after injury.
011
Reposted by RASopathies Network
Dr. Lucky Tran @luckytran.com · 20/08/2026
AI did not discover a cancer vaccine. Scientists discovered it because their research was supported and funded.
161026231
Reposted by RASopathies Network
Anh Hoang Le, PhD 🏳️‍🌈🏴󠁧󠁢󠁳󠁣󠁴󠁿🇻🇳 @anhhle2702.bsky.social · 21/08/2026
Another #FluorescenceFriday. Found this cool macrophage so had to dedicate 5min of my imaging time to capture it. This cell forms a massive ring of podosomes on the substrate. Kinda reminds me of Sauron's eye. They're so versatile. Lamellipodia, filopodia, blebs, you name it. The best cells 🙌!
0286
Reposted by RASopathies Network
Nael Nadif Kasri @naelnadifkasri-lab.bsky.social · 20/08/2026
Happy to share this new study with close and long-time collaborator Tjitske Kleefstra. Using a back translation approach we uncovered a crucial role for astrocytes in Kleefstra Syndrome and how they can explain the positive response of patients to Olanzapine.
062
Reposted by RASopathies Network
RASopathies Network @rasnet.bsky.social · 20/08/2026
🧪🫀💊 Rigosertib Reverses Hypertrophic Cardiomyopathy in Noonan Syndrome | Circulation Preclinical fly and mouse data and comparison with MEKi trametinib. Exciting findings.... www.ahajournals.org/doi/10.1161/...
ahajournals.org
Rigosertib Reverses Hypertrophic Cardiomyopathy in Noonan Syndrome | Circulation
BACKGROUND: RASopathies constitute a group of rare genetic disorders caused by mutations in genes along the canonical RAS/mitogen-activated protein kinase (MAPK) signaling pathway, affecting cell grow...
121
RASopathies Network @rasnet.bsky.social · 20/08/2026
🧪🫀💊 Rigosertib Reverses Hypertrophic Cardiomyopathy in Noonan Syndrome | Circulation Preclinical fly and mouse data and comparison with MEKi trametinib. Exciting findings.... www.ahajournals.org/doi/10.1161/...
ahajournals.org
Rigosertib Reverses Hypertrophic Cardiomyopathy in Noonan Syndrome | Circulation
BACKGROUND: RASopathies constitute a group of rare genetic disorders caused by mutations in genes along the canonical RAS/mitogen-activated protein kinase (MAPK) signaling pathway, affecting cell grow...
121
Reposted by RASopathies Network
Eric Topol @erictopol.bsky.social · 19/08/2026
mRNA vaccines vs cancer success —melanoma (Phase 3, RCT, definitive, announced today) —triple negative breast cancer —pancreatic cancer —non-small cell lung cancer —glioblastoma
8534181045
Reposted by RASopathies Network
Pablo J. Sáez @pjsaez.bsky.social · 18/08/2026
#cytoskeleton So, there is a small (very small) 9-aa motif that is an evolutionary conserved anchor to actin. It's named: short linear actin filament-binding motif (SFM), and it's *the same* found in LifeAct ! Full: www.nature.com/articles/s41... @natcellbio.nature.com @cellclub.bsky.social 🧪🔬
091
RASopathies Network @rasnet.bsky.social · 13/08/2026
Dr. Stieglitz will study daraxonrasib in JMML (juvenile myelomonocytic leukemia). JMML is associated with certain PTPN11 variants in Noonan syndrome. #pediatrics #oncosky lnkd.in/p/eDZZ32-x
lnkd.in
Daraxonrasib: A Promising Cancer Drug for 2026 | Elliot Stieglitz posted on the topic | LinkedIn
What is the most important cancer drug of 2026? Hands down, that's daraxonrasib. A first-in-class, direct inhibitor of RAS (previously thought to be impossible) that has transformed the field of panc...
000
Reposted by RASopathies Network
RASopathies Network @rasnet.bsky.social · 12/08/2026
Thanks Bronsted
011
Reposted by RASopathies Network
RASopathies Network @rasnet.bsky.social · 12/08/2026
#RASDialogueBlog Advancing RAS/RASopathies Therapies @NCI ‘s Frederick National Lab 🧪 #medsky #pediatrics #oncosky www.linkedin.com/posts/freder...
linkedin.com
Rethinking rare disease: How the ART Initiative is connecting genomics, the clinic, and the lab bench for RASopathies | Frederick National Laboratory | Frederick National Laboratory for Cancer Researc...
What happens when you build a collaboration on the foundation of connecting population genomics, longitudinal patient follow-up, and laboratory models into one continuous loop? In this month's #RASDia...
101
RASopathies Network @rasnet.bsky.social · 12/08/2026
#RASDialogueBlog Advancing RAS/RASopathies Therapies @NCI ‘s Frederick National Lab 🧪 #medsky #pediatrics #oncosky www.linkedin.com/posts/freder...
linkedin.com
Rethinking rare disease: How the ART Initiative is connecting genomics, the clinic, and the lab bench for RASopathies | Frederick National Laboratory | Frederick National Laboratory for Cancer Researc...
What happens when you build a collaboration on the foundation of connecting population genomics, longitudinal patient follow-up, and laboratory models into one continuous loop? In this month's #RASDia...
101
RASopathies Network @rasnet.bsky.social · 12/08/2026
Thanks Bronsted
011
RASopathies Network @rasnet.bsky.social · 10/08/2026
Wow, That's stark. I'd like to see some more funding for science and clinical trials for treatments.
010
Reposted by RASopathies Network
RASopathies Network @rasnet.bsky.social · 06/08/2026
🙌🏻From the Spence lab. We hope these expt models will shed light on GI problems experienced by kids with RASopathies. What is RAS/Mapk doing in all those gut and intestinal cell types? Maybe its the confluence of muscle, neuron, lymphatic, endocrine, and endothelial dysfunction. 🤷🏼‍♀️💩 🧪
011
RASopathies Network @rasnet.bsky.social · 06/08/2026
Clinical implications of RAS mutations in AML: prognostic significance is based upon the involved gene and mutation complexity ashpublications.org/bloodadvance...
ashpublications.org
Clinical implications of RAS mutations in AML: prognostic significance is based upon the involved gene and mutation complexity
Key PointsComplex mutations in KRAS predict poor outcomes in AML; complex NRAS and KRAS mutations confer an inferior prognosis in KMT2A-r AML.Noncomplex KR
000
RASopathies Network @rasnet.bsky.social · 06/08/2026
🙌🏻From the Spence lab. We hope these expt models will shed light on GI problems experienced by kids with RASopathies. What is RAS/Mapk doing in all those gut and intestinal cell types? Maybe its the confluence of muscle, neuron, lymphatic, endocrine, and endothelial dysfunction. 🤷🏼‍♀️💩 🧪
011
Reposted by RASopathies Network
Craig M. Crews @craigmcrews.bsky.social · 06/08/2026
HuR degradation reveals dependencies in BRAF-driven cancers: Trends in Cancer www.cell.com/trends/cance...
cell.com
HuR degradation reveals dependencies in BRAF-driven cancers
Targeting RNA-binding proteins has been shown to be challenging due to the absence of druggable pockets. Recently, Lu et al. identified a molecular glue capable of degrading HuR and suppressing BRAF-m...
071
Reposted by RASopathies Network
Cincinnati Children’s Research @cincyresearch.bsky.social · 06/08/2026
Cincinnati Children's has received a six-year, $38.4M NIH grant renewal to lead the next phase of the Bench to Bassinet Program. The new initiative, B2B CHANGE, will connect genomic discoveries to long-term health outcomes and future care needs. Congratulations to the team behind this work!
scienceblog.cincinnatichildrens.org
$38.4 Million NIH Grant Renewal to Expand Landmark Congenital Heart Disease Genomics Program - Research Horizons
Cincinnati Children’s receives a $38.4 million NIH grant renewal to expand Bench to Bassinet, a national congenital heart disease genomics program.
022
Reposted by RASopathies Network
Jason Nagata, MD @jasonmnagata.bsky.social · 03/08/2026
🗣️ New @ucsfchildrens.bsky.social study in @ajpmonline.bsky.social! 🧠Adolescents in the low-to-moderate and moderate-to-high problematic social media use trajectories had lower cognitive performance 🔗 Read here: tinyurl.com/socmind @theabcdstudy.bsky.social
122
Reposted by RASopathies Network
News Medical @newsmedical.bsky.social · 04/08/2026
A major US trial finds silver diamine fluoride can effectively stop severe tooth decay in young kids - offering a quick, noninvasive alternative to complex dental work! 🦷✨ www.news-medical.net/news/2026080... #Pediatrics #Dentistry @jamapediatrics.com
news-medical.net
Large US trial supports silver diamine fluoride for severe early childhood caries
A phase 3 randomized trial of 830 young children with severe early childhood caries found that 38% silver diamine fluoride arrested 54.0% of eligible cavitated dentin lesions at six months, compared w...
001